Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with Stage III Soft Tissue Sarcomas of the Extremity By Ogkologos - December 2, 2024 515 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SU2C-SARC032 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR Experimental CAR T-Cell Therapy Shrinks Tumors in Children with Deadly Brain... January 2, 2025 FDA Approves Lazertinib with Amivantamab-vmjw for Locally Advanced or Metastatic NSCLC... September 9, 2024 Commemorating the Contributions of Cancer Research Greats March 12, 2021 How Does CAR T-Cell Therapy Work in Treating Cancer? June 17, 2021 Load more HOT NEWS Higher Risk of Heart Failure Seen in Some Cancers Cancer Research UK honours Her Majesty The Queen, the charity’s Patron More than 65,000 people are left waiting to find out if... Man Gets His First Haircut In 15 Years To Join The...
